TY - JOUR
T1 - Pedobarometric evaluation of equinus foot disorder after injection of botulinum toxin A in children with cerebral palsy
T2 - A pilot study
AU - Falso, Maurizio
AU - Fiaschi, A.
AU - Manganotti, P.
PY - 2005/6
Y1 - 2005/6
N2 - The purpose of this pilot study was to evaluate the effect of treatment with botalinum toxin A (BTX-A) injections on function in children with cerebral palsy (CP) using pedobarometric data collected in a standing position. Ten children with CP (seven males, three females) participated, five with diplegia and five with hemiplegia. All children exhibited signs of unilateral dynamic equinus foot disorder and were community ambulators. Age range at the time of treatment was 6 to 13 years (mean age 9y, SD 2.5). A comprehensive clinical examination and a pedobarometric evaluation were performed before and after BTX-A injection. All children received at least one injection in each spastic muscle. BTX-A was given to eight children unilaterally and to two children bilaterally. A maximum dose of 4 to 8 units of BTX-A per kilogram body weight was administered. In comparison with pretreatment values, the pedobarometric evaluation revealed a significant increase in the whole plantar surface area on the affected side (p
AB - The purpose of this pilot study was to evaluate the effect of treatment with botalinum toxin A (BTX-A) injections on function in children with cerebral palsy (CP) using pedobarometric data collected in a standing position. Ten children with CP (seven males, three females) participated, five with diplegia and five with hemiplegia. All children exhibited signs of unilateral dynamic equinus foot disorder and were community ambulators. Age range at the time of treatment was 6 to 13 years (mean age 9y, SD 2.5). A comprehensive clinical examination and a pedobarometric evaluation were performed before and after BTX-A injection. All children received at least one injection in each spastic muscle. BTX-A was given to eight children unilaterally and to two children bilaterally. A maximum dose of 4 to 8 units of BTX-A per kilogram body weight was administered. In comparison with pretreatment values, the pedobarometric evaluation revealed a significant increase in the whole plantar surface area on the affected side (p
UR - http://www.scopus.com/inward/record.url?scp=19644362057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19644362057&partnerID=8YFLogxK
U2 - 10.1017/S0012162205000770
DO - 10.1017/S0012162205000770
M3 - Article
C2 - 15934488
AN - SCOPUS:19644362057
SN - 0012-1622
VL - 47
SP - 396
EP - 402
JO - Developmental Medicine and Child Neurology
JF - Developmental Medicine and Child Neurology
IS - 6
ER -